Recent Stock Purchase II – January 2017

I added positions in 5 existing companies in second week of January. I plan to keep adding these dividend growth stocks to grow my passive dividend income to a point where all my expenses are covered by passive income generated by them.

Below are the companies where I put my capital on towards my race for earning $3000 per month in 3000 days. Last month, I completed 60days of my freedom race and it was nice to have crossed $1700 in passive income for the first time ever. Without further ado:

1) Anheuser-Busch InBev (BUD): 5 positions at $106.01 on 1/13
2) Gilead Sciences, Inc. (GILD): 5 positions at $73.63 on 1/13
3) CVS Pharmacy (CVS): 5 positions at $82.69 on 1/13
4) National Health Inv. Inc. (NHI): 5 positions at $73.96 on 1/13
5) Toronto-Dominion Bank (TD): 5 positions at $51.25 on 1/13

Due to addition of new companies over last several months and splits of HCPYUM and sale of APPL, total count is getting closing to a century mark in my portfolio.

Full Disclosure: Long on above mentioned stocks.

10 thoughts on “Recent Stock Purchase II – January 2017

    • Hi Doug,

      Thank you. I’m working slow and steady though market appears little over-valued looking at CAPE and PE ratios. Thanks for stopping by and commenting.

    • Hi BHL,

      Appreciate the likes. Nibbling on some of the companies to add to the flow and achieve my dream of $3K in 3K. Thanks for stopping by and commenting.

    • Hi DT,

      It was a rare occasion when other companies appeared more valuable than APPL. So, sold it to make way for others. However, hindsight is 20/20 and I should not have sold. Most likely, will add APPL again at some point. Thanks for stopping by and commenting.

    • Hi PID,

      Great minds think alike. Pharma companies are selling at great valuation due to heightened risks of new regulations. Its quite possible there is some more downside to go, however, with graying of population, healthcare segment is a go for me. Thanks for stopping by and commenting.

  1. These are some great buys. I used to hold BUD before it was bought out. In fact, it was one of my original holdings in my dividend growth portfolio. GILD still on my watch list as well as NHI and LTC in the health REIT space. Of course, you already know I like the Canadian banks too. Nice buys all around.

    • Hi DH,

      I saw that. I like BUD at current valuations along with GILD and PFE. I’ve looked at LTC but have not pulled the trigger: too many companies but less capital available 🙂 Canadian banks are high on my list as well. Thanks for stopping by as always.

Leave a Reply

Your email address will not be published. Required fields are marked *